From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA accepts Depomed's hot flash drug for review

from The Associated Press via Bloomberg Businessweek

The Food and Drug Administration will review Depomed Inc.'s potential treatment for menopausal hot flashes and may decide its fate by next spring. Depomed, based in Menlo Park, Calif., said that the FDA accepted Serada for a standard review and aims to complete its evaluation by May 31. Depomed had submitted the drug's application to regulators on July 31. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063